Analysts have raised their fair value estimate for Ansell from A$35.15 to A$36.77. They cited that the shares appear undervalued relative to forecast risks and the current discount in the stock price.
Analyst Commentary
Recent street research on Ansell has highlighted a range of views regarding the company's valuation and prospects. While some analysts have upgraded the stock, perspectives remain divided on potential risks and areas for caution.
Bullish Takeaways
- Bullish analysts view Ansell's current stock price as undervalued, suggesting that the discount in the share price outweighs the foreseeable risks.
- The fair value estimate revision, together with a steady price target, implies confidence in the company's long-term fundamentals and business strategy.
- Analysts believe that potential headwinds, such as tariffs on healthcare personal protective equipment, are already factored into the share price and are less impactful than currently perceived.
- There is a consensus among optimistic analysts that the current valuation provides a compelling entry point for investors, pointing to resilient demand in Ansell’s core markets and solid execution.
Bearish Takeaways
- Bearish analysts remain cautious about macroeconomic uncertainties that could impact Ansell's operating environment and limit growth potential.
- There are concerns that ongoing or future tariffs could introduce unforeseen costs and margin pressures, particularly for the healthcare segment.
- Some remain wary that forecast risks, while possibly overstated in recent price action, could still pose challenges if market or regulatory conditions worsen.
What's in the News
- The Board of Directors of Ansell Limited has authorized a buyback plan, which was announced on August 25, 2025. (Key Developments)
- Ansell Limited (ASX:ANN) will repurchase up to 14,594,488 shares, representing 10% of its issued share capital. This buyback is part of a capital management strategy and is valid until September 7, 2026. (Key Developments)
- Ansell is actively seeking acquisitions to strengthen its position, with a focus on productivity investments such as greater automation in key manufacturing processes, according to CFO Brian Montgomery. (Key Developments)
Valuation Changes
- Fair Value Estimate has risen from A$35.15 to A$36.77, marking a modest increase in analysts' assessed intrinsic value.
- Discount Rate has increased slightly from 7.46% to 7.49%.
- Revenue Growth forecast has decreased marginally, moving from 4.85% to 4.80%.
- Net Profit Margin projection has edged lower, dropping from 10.22% to 10.19%.
- Future P/E ratio estimate has fallen significantly from 26.6x to 18.0x. This reflects a materially reduced valuation multiple for expected earnings.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.